Esophageal Varices-II: Clinical Features and Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Endoscopic Procedures II: Colonoscopy
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Endoscopic Procedures I: Esophagogastroduodenoscopy
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 29, 2025

Microsurgical Venous Pouch Arterial-Bifurcation Aneurysms in the Rabbit Model: Technical Aspects
Published on: May 11, 2011
Sayo Kobayashi1, Keita Harada2,3, Toru Nawa1
1Department of Internal Medicine, Fukuyama City Hospital, Fukuyama, JPN.
Continuing oral anticoagulants during endoscopic mucosal resection (EMR) for colorectal cancer is safe, with a low major bleeding rate of 4.7%. This approach is a viable alternative to heparin bridging, minimizing both bleeding and thrombotic risks.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: